HSA Approval

PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/VIAL

Approval Number

SIN15856P

Drug Name

Product Name

PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/VIAL

Approval Date

November 18, 2019

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

J02AX04

ATC Item Name

caspofungin

Manufacturer Information

Pharmaceutical Manufacturer

RANBAXY (MALAYSIA) SDN. BHD.

Manufacturers

MEFAR İLAÇ SANAYİİ A.Ş.(Primary & Secondary packager)

Active Ingredients

Ingredient Name

Caspofungin Acetate 77.69mg equivalent to Caspofungin

Strength

70mg/vial

Drug MonographCaspofungin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/VIAL - HSA Approval | MedPath

AI-Powered Research

Premium Access

PERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/VIAL

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal